Related Experiment Video
Updated: Jan 2, 2026

07:13
Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
2.0K
FRET-Created Traffic Light Immunoassay Based on Polymer Dots for PSA Detection
Yong-Quan Yang1, Yu-Chi Yang1, Ming-Ho Liu1
1Department of Applied Chemistry, National Chiao Tung University, Hsinchu 30010, Taiwan.
Analytical Chemistry
|December 10, 2019
Summary
Researchers developed a novel traffic light immunoassay test strip using polymer dots for rapid prostate-specific antigen (PSA) detection. This advanced fluorometric lateral flow assay offers high sensitivity and potential for multiplexed cancer biomarker screening.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- Fluorometric lateral flow immunochromatographic strips (ICTS) are advancing rapidly due to new fluorescent materials.
- Developing sensitive and specific diagnostic tools for early disease detection is crucial.
Purpose of the Study:
- To develop a novel fluorometric ICTS using semiconducting polymer dots (Pdots) for rapid and sensitive detection of biomarkers.
- To demonstrate the platform's capability for both qualitative and quantitative analysis, including multiplexed detection.
Main Methods:
- Fabrication of an ICTS utilizing ultrabright Pdots as fluorescent reporters.
- Implementation of Förster Resonance Energy Transfer (FRET) to generate concentration-dependent "traffic light" signals.
- Application of the platform for prostate-specific antigen (PSA) detection in whole blood samples.
Main Results:
- The developed ICTS achieved rapid (10 min) qualitative and quantitative analysis of PSA from a single drop of blood.
- The assay demonstrated excellent specificity and a high detection sensitivity of 0.32 ng/mL for PSA.
- Proof-of-concept experiments confirmed the potential for simultaneous multiplexed detection of cancer biomarkers.
Conclusions:
- The Pdot-based traffic light ICTS represents a significant advancement in point-of-care diagnostics.
- This novel platform offers high sensitivity, specificity, and multiplexing capabilities for cancer biomarker detection.
- The technology paves the way for next-generation diagnostic tools with enhanced performance and versatility.

